Abstract
A synthetic gene coding for the coat protein of tobacco mosaic virus (TMVCP) was expressed in E. coli under the direction of the lacUV5 promoter. Modification of the 3′ end of the TMVCP gene by insertion of a region coding for an antigenic epitope from poliovirus type 3 resulted in the production of a hybrid TMVCP (TMVCP–polio 3). Both the E. coli–produced TMVCP and TMVCP–polio 3 were shown to assemble into virus–like rods under acidic conditions in E. coli extracts. Their purification was accomplished in a single step by chromatography on Sepharose 6B. TMVCP–polio 3 induced the formation of poliovirus neutralizing antibodies following injection into rats. The level of immune response was related to the degree of polymerization of the TMVCP–polio 3 preparations.
Similar content being viewed by others
Article PDF
References
Chow, M., Yabrov, R., Bittle, J., Hogle, J., and Baltimore, D. 1985. Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies. Proc. Natl. Acad. Sci. USA 82:910–914.
Nestorowicz, A., Tregear, G.W., Southwell, C.N., Martyn, J., Murray, J.M., White, D.O., and Jackson, D.C. 1985. Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites. Molecular Immunology 22:145–154.
Almond, J.W., Stanway, G., Cann, A.J., Westrop, G.D., Evans, D.M.A., Ferguson, M., Minor, P.D., Spitz, M., and Schild, G.C. 1984. New poliovirus vaccines: a molecular approach. Vaccine 2:177–184.
Hopp, T.P. 1984. Immunogenicity of a synthetic HBsAg peptide: enhancement by conjugation to a fatty acid carrier. Molecular Immunology 21:13–16.
Shapira, M., Jibson, M., Muller, G., and Arnon, R. 1984. Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin. Proc. Natl. Acad. Sci. USA 81:2461–2465.
Emini, E.A., Jameson, B.A., and Wimmer, E. 1983. Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature 304:699–703.
Gerin, J.L., Alexander, H., Shih, J.W.-K., Purcell, R.H., Dapolito, G., Engle, R., Green, N., Sutcliffe, J.G., Shinnick, T.M., and Lerner, R.A. 1983. Chemically synthesized peptides of hepatitis B surface antigen duplicate the d/y specificities and induce subtype-specific antibodies in chimpanzees. Proc. Natl. Acad. Sci. USA 80:2365–2369.
Neurath, A.R., Kent, S.B.H., and Strick, N. 1982. Specificity of antibodies elicited by a synthetic peptide having a sequence in common with a fragment of a virus protein, the hepatitis B surface antigen. Proc. Natl. Acad. Sci. USA 79:7871–7875.
Dreesman, G.R., Sanchez, Y., Ionescu-Matiu, I., Sparrow, J.T., Six, H.R., Peterson, D.L., Hollinger, F.B., and Melnick, J.L. 1982. Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides. Nature 295:158–160.
Lerner, R.A., Green, N., Alexander, H., Liu, F.-T., Sutcliffe, G., and Shinnick, T.M. 1981. Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc. Natl. Acad. Sci. USA 78:3403–3407.
Butler, P.J.G. 1984. The current picture of the structure and assembly of tobacco mosaic virus. J. Gen. Virol. 65:253–279.
Grosjean, H., and Fiers, W. 1982. Preferential codon usage in prokaryotic genes: the optimal codon-anticodon energy and the selective codon usage in efficiently expressed genes. Gene 18:199–209.
Goelet, P., Lomonossoff, G.P., Butler, P.J.G., Akam, M.E., Gait, M.J., and Karn, J. 1982. Nucleotide sequence of tobacco mosaic virus RNA. Proc. Natl. Acad. Sci. USA 79:5818–5822.
Fuller, F. 1982. A family of cloning vectors containing the lacUV5 promoter. Gene 19:43–54.
Evans, D.M.A., Minor, P.D., Schild, G.S., and Almond, J.W. 1983. Critical role of an eight-amino acid sequence of VP1 in neutralization of poliovirus type 3. Nature 304:459–462.
Durham, A.C.H. and Klug, A. 1972. Structures and roles of the polymorphic forms of tobacco mosaic virus protein. III. A model for the association of A-protein into disks. J. Mol. Biol. 67:315–332.
Durham, A.C.H. and Finch, J.T. 1972. Structures and roles of the polymorphic forms of tobacco mosaic virus protein. II. Electron microscopic observations of the larger polymers. J. Mol. Biol. 67:307–314.
Valenzuela, P., Coit, D., Medina-Selby, A., Kuo, C., Van Nest, G., Burke, R.L., Bull, P., Urdea, M.S., and Graves, R.V. 1985. Antigen engineering in yeast: Synthesis and assembly of hybrid hepatitis B surface antigen-herpes simplex 1 gD particles. BioTechnology 3:323–326.
Gordon, L.K. 1984. Characterization of a hapten-carrier conjugate vaccine: H. influenzae-diphtheria conjugate vaccine, p. 393–396 In: Modern Approaches to Vaccines. R. M. Chanock and R. A. Lerner (eds.) Cold Spring Harbor, NY.
Schutze, M.-P., Leclerc, C., Jolivet, M., Audibert, F., and Chedid, L. 1985. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J. Immunology 135:2319–2322.
Sanger, F. and Coulson, A.R. 1978. The use of thin polyacrylamide gels for DNA sequencing. FEBS Lett. 87:107–110.
Clarke, P., Lin, H.-C., and Wilcox, G. 1982. Ultraviolet imaging: a simple method for detecting nucleic acids in preparative gels. Analytical Biochem. 124:88–91.
Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685.
Lee, C.-Y.G., Huang, Y.-S., Hu, P.-C., Gomer, V., and Menge, A.C. 1982. Analysis of sperm antigens by sodium dodecyl sulfate gel/protein blot radioimmunobinding method. Analytical Biochem. 123:14–22.
van Steenis, G., van Wezel, A.L., and Sekhuis, V.M. 1981. Potency testing of killed polio vaccine in rats. Dev. Biol. Stand. 47:119–128.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haynes, J., Cunningham, J., von Seefried, A. et al. Development of a Genetically–Engineered, Candidate Polio Vaccine Employing the Self–Assembling Properties of the Tobacco Mosaic Virus Coat Protein. Nat Biotechnol 4, 637–641 (1986). https://doi.org/10.1038/nbt0786-637
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0786-637
This article is cited by
-
Recombinant helical plant virus-based nanoparticles for vaccination and immunotherapy
Virus Genes (2018)
-
Plant viruses as scaffolds for the presentation of vaccine epitopes
Biologia plantarum (2017)
-
Recent developments in therapeutic protein expression technologies in plants
Biotechnology Letters (2015)
-
Potato Virus M-Like Nanoparticles: Construction and Characterization
Molecular Biotechnology (2015)
-
Construction and Characterization of Virus-Like Particles: A Review
Molecular Biotechnology (2013)